Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CD4 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 526 entities in the SciDEX knowledge graph.
| Gene Symbol | CD4 |
| Chromosome | 12p13.31. |
| Protein Family | Immunoglobulin superfamily |
| Protein Type | Receptor |
| Function | Binding to MHC class II molecules on antigen-presenting cells |
| Molecular Weight | ~55 kDa (glycosylated) |
| Pathways | Amyloid, Apoptosis, Autophagy, Complement, Differentiation |
| UniProt ID | P01730 |
| NCBI Gene ID | 921 |
| Ensembl ID | ENSG00000149257 |
| GeneCards | CD4 |
| Human Protein Atlas | CD4 |
| Gene Name | Cluster of Differentiation 4 |
| Agent | Mechanism |
| Natalizumab | α4-integrin blocker |
| Associated Diseases | ALS, Aging, Alzheimer, Atherosclerosis, Autoimmune |
| Known Drugs/Compounds | FINGOLIMOD |
| Interactions | PRDM1, FOXP3, CD8, HMOX1, OCLN, MAF |
| KG Connections | 1025 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
CD4["CD4<br/>T-helper cell receptor"]
CD4 --|"regulates"|--> Neuroinflammation["Neuroinflammation<br/>Process"]
CD4 --|"activates"|--> MS_activation["Multiple Sclerosis<br/>Activation"]
CD4 --|"inhibits protective"|--> ALS_protection["ALS<br/>Neuroprotection"]
CD4 --|"regulates"|--> PD_pathology["Parkinson's Disease<br/>Pathology"]
CD4 --|"biomarker"|--> ALS_progression["ALS<br/>Disease Progression"]
CD4 --|"therapeutic target"|--> MS_treatment["MS<br/>Therapeutic Intervention"]
Neuroinflammation --|"promotes"|--> Neurodegeneration["Neurodegeneration<br/>Process"]
Neuroinflammation --|"contributes to"|--> Dementia_risk["Dementia<br/>Risk Development"]
MS_activation --|"drives"|--> Autoimmune_response["Autoimmune<br/>Response"]
MS_activation --|"leads to"|--> Myelin_damage["Myelin<br/>Degradation"]
ALS_protection --|"loss results in"|--> Motor_neuron_death["Motor Neuron<br/>Degeneration"]
PD_pathology --|"accelerates"|--> Dopaminergic_loss["Dopaminergic<br/>Neuron Loss"]
Autoimmune_response --|"triggers"|--> CNS_inflammation["CNS<br/>Inflammation"]
CNS_inflammation --|"exacerbates"|--> Neurodegeneration
CD4 --|"regulates"|--> Aging_process["Cellular<br/>Aging Process"]
Aging_process --|"increases risk"|--> Neurodegeneration
MS_treatment --|"targets"|--> CD4_modulation["CD4+ T-cell<br/>Modulation"]
CD4_modulation --|"reduces"|--> Neuroinflammation
style CD4 fill:#006494
style MS_treatment fill:#1b5e20
style CD4_modulation fill:#1b5e20
style ALS_protection fill:#1b5e20
style Neuroinflammation fill:#ef5350
style MS_activation fill:#ef5350
style Autoimmune_response fill:#ef5350
style CNS_inflammation fill:#ef5350
style Neurodegeneration fill:#5d4400
style Motor_neuron_death fill:#5d4400
style Dementia_risk fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | regulates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Brain Inflammation | mediates | process | 0.95 |
| Als | regulates | disease | 0.95 |
| Als | inhibits | disease | 0.95 |
| Neurodegeneration | mediates | process | 0.95 |
| T CELLS | interacts_with | cell_type | 0.95 |
| Parkinson's Disease | contributes_to | disease | 0.90 |
| T cells | associated_with | cell_type | 0.90 |
| Als | activates | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Inflammation | associated_with | disease | 0.85 |
| Inflammation | inhibits | disease | 0.85 |
| Dementia | contributes_to | disease | 0.80 |
| T cells | regulates | cell_type | 0.80 |
| T cells | expressed_in | cell_type | 0.80 |
| Immune Response | regulates | pathway | 0.80 |
| Immune Response | activates | pathway | 0.80 |
| Cancer | expressed_in | disease | 0.75 |
| Als | expressed_in | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Multiple Sclerosis | therapeutic_target | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Tumor | inhibits | disease | 0.75 |
| Tumor | expressed_in | disease | 0.75 |
| Autoimmune | activates | disease | 0.75 |
| Autoimmune | therapeutic_target | disease | 0.75 |
| Aging | associated_with | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Carcinoma | expressed_in | disease | 0.75 |
| Carcinoma | inhibits | disease | 0.75 |
| Ulcerative Colitis | regulates | disease | 0.75 |
| Sepsis | activates | disease | 0.75 |
| Rheumatoid Arthritis | activates | disease | 0.75 |
| Als | causes | disease | 0.75 |
| Infection | activates | disease | 0.75 |
| Parkinson | activates | disease | 0.75 |
| Neuroinflammation | inhibits | disease | 0.75 |
| Infection | regulates | disease | 0.75 |
| Inflammation | implicated_in | disease | 0.75 |
| Infection | associated_with | disease | 0.75 |
| FOXP3 | activates | gene | 0.70 |
| primary open-angle glaucoma | biomarker_for | disease | 0.70 |
| CD8 | inhibits | gene | 0.70 |
| MTOR | activates | gene | 0.70 |
| CD8 | therapeutic_target | gene | 0.70 |
| B cells | associated_with | cell_type | 0.70 |
| Autophagy | regulates | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | regulates | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| VPU | degrades | protein | 0.95 |
| PTPN23 | mediates | protein | 0.85 |
| CD19 | associated_with | gene | 0.80 |
| CD8 | associated_with | gene | 0.80 |
| AKT | activates | gene | 0.80 |
| tumor | expressed_in | cell_type | 0.70 |
| FOXP3 | activates | gene | 0.70 |
| FOXP3 | regulates | gene | 0.70 |
| CYTOKINES | expressed_in | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| PARKINSON'S DISEASE | activates | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| ERK | activates | gene | 0.70 |
| INFLAMMATION | associated_with | gene | 0.70 |
| INFLAMMATION | implicated_in | gene | 0.70 |
| JUN | regulates | gene | 0.60 |
| TGFB1 | regulates | gene | 0.60 |
| MAF | inhibits | gene | 0.60 |
| CD8 | inhibits | gene | 0.60 |
| CD14 | therapeutic_target | gene | 0.60 |
| RORC | therapeutic_target | gene | 0.60 |
| CD8 | expressed_in | gene | 0.60 |
| OCLN | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
| DNAJA2 | regulates | gene | 0.60 |
| PRDM1 | inhibits | gene | 0.60 |
| TRAF6 | biomarker_for | gene | 0.60 |
| P38 | biomarker_for | gene | 0.60 |
| RORC | associated_with | gene | 0.60 |
| STAR | expressed_in | gene | 0.60 |
| TNF | expressed_in | gene | 0.60 |
| AKT | causes | gene | 0.60 |
| ROBO1 | expressed_in | gene | 0.60 |
| CD14 | activates | gene | 0.60 |
| JAK1 | inhibits | gene | 0.60 |
| UBIQUITIN | inhibits | gene | 0.60 |
| JNK | regulates | gene | 0.60 |
| TNF | treats | gene | 0.60 |
| S100A6 | regulates | gene | 0.60 |
| CXCL2 | treats | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| EGF | implicated_in | gene | 0.60 |
| SOCS3 | activates | gene | 0.60 |
| FOXP3 | inhibits | gene | 0.60 |
| CD63 | inhibits | gene | 0.60 |
| CD81 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||